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Abstract
Noradrenergic neuronal identity and differentiation are controlled by cascades of transcription factors acting downstream of BMP4,
including the basic helix–loop–helix DNA binding protein HAND2 and the homeodomain factor Phox2a. Dopamine--hydroxylase (DBH)
is the penultimate enzyme required for synthesis of norepinephrine and is thus a noradrenergic cell type-specific marker. We have examined
the interaction of HAND2 and Phox2a at the DBH promoter. Using transient transfection of P19 or NT-2 cells, HAND2 is shown to
synergistically enhance Phox2a-driven transcriptional activity at the DBH promoter, an effect that is enhanced by cAMP. While mutation
of the Phox2a homeodomain binding sites HD1, HD2, and HD3 results in the loss of HAND2/Phox2a transactivation of DBH, it is the
interaction of HAND2/Phox2a at the CRE/AP1-HD1/2 domains in the DBH enhancer that are required for synergistic activation by HAND2.
We find that HAND2 functions as a transcriptional activator without directly binding to E-box sequences in the DBH promoter, suggesting
that HAND2-mediated DBH activity occurs by protein–protein interactions with other transcriptional regulators. Although we were unable
to detect interaction of HAND2 and Phox2a in IP/Western blots, HAND2 synergistic activation of DBH is blocked by E1A, suggesting that
HAND2 interacts with CBP (cAMP response element binding protein) in this transcriptional complex. In the presence of the putative
HAND2 dimerization partner, E12, synergistic activation of DBH transcription is titrated away, suggesting that HAND2 does not
functionally dimerize with E12 in the DBH transcription complex. Our data suggest that HAND2 regulates cell type-specific expression of
norepinephrine in concert with Phox2a by a novel mechanism.
© 2003 Elsevier Inc. All rights reserved.
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Introduction
The neural crest gives rise to neurons comprising periph-
eral autonomic, sensory, and enteric ganglia, but the under-
lying mechanisms responsible for generating phenotypic
diversity in these neurons remain poorly understood. To
address this issue, we have focused on the generation of
neural crest-derived peripheral noradrenergic sympathetic
ganglion neurons. The differentiation of these neurons has
provided a useful model in which to identify clusters of
DNA binding proteins required for the acquisition of both
pan-neuronal and cell type-specific patterns of gene expres-
sion.
The differentiation of sympathetic ganglion neurons is
regulated by a complex of transcriptional regulators, includ-
ing the basic helix–loop–helix (bHLH) DNA binding pro-
teins HAND2 (dHAND) (Howard et al., 1999, 2000) and
MASH1 (Guillemot et al, 1993; Hirsch et al., 1998; Lo et
al., 1998), as well as the paired homeodomain transcription
factors Phox2a and Phox2b (Morin et al., 1997; Pattyn et al.,
1997, 1999; Lo et al., 1999; Stanke et al 1999). In a pathway
parallel to MASH1, Phox2b, HAND2, and Phox2a function
sequentially in the coordinated regulation of cell type-spe-
cific and pan-neuronal genes characteristic of noradrenergic
neurons (Howard et al., 2000). Both the temporal expression
pattern of transcripts encoding Phox2 proteins and HAND2
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and ectopic patterns of expression have placed Phox2b
upstream and Phox2a downstream of HAND2 (Howard et
al., 2000). Bone morphogenetic protein 4 (BMP4), derived
from the dorsal aorta, is an upstream factor which induces
expression of Phox2b and subsequently HAND2 (Reiss-
mann et al., 1996; Stanke et al., 1999; Howard et al., 2000).
The expression of enzymes required for synthesis of
norepinephrine is one hallmark of a differentiated noradren-
ergic neuron. The transcription of tyrosine hydroxylase
(TH) and dopamine--hydroxylase (DBH), the rate limiting
and penultimate enzymes in the norepinephrine biosynthetic
pathway, is regulated by Phox2 proteins (Zellmer et al.,
1995; Swanson et al., 1997, 1998; Yang et al., 1998). In
rodent neural crest-derived cells, Phox2a alone was insuf-
ficient to support expression of noradrenergic characteristics
(Lo et al., 1998), but coactivation by cAMP/PKA resulted in
expression of TH (Lo et al., 1999). BMP2, in concert with
Phox2a and PKA, induced TH, DBH, as well as neuronal
differentiation (Lo et al., 1999), suggesting a role for Phox2
proteins in both expression of pan-neuronal characteristics
as well as regulation of noradrenergic neurotransmitter
identity. Since expression of Phox2a alone was insufficient
to support neuronal differentiation, this raised the possibil-
ity of additional DNA binding proteins that might function
in concert with Phox2a. HAND2 is a likely candidate since
overexpression of HAND2 is sufficient to induce transcripts
encoding Phox2a and supports synthesis of norepinephrine
as well as expression of pan-neuronal marker genes
(Howard et al., 1999, 2000). We directly tested the hypoth-
esis that HAND2 and Phox2a coordinately regulate the
activity of the noradrenergic cell type-specific gene, DBH,
by assessing potential interactions of HAND2 and Phox2a
at the DBH promoter and effects of cAMP on DBH pro-
moter activity. Our results demonstrate that HAND2 syner-
gistically enhances Phox2a activity via a DNA-binding in-
dependent mechanism at the DBH promoter most likely in




P19 cells were maintained in alpha minimal essential
medium (-MEM) supplemented with 7.5% bovine calf
serum and 2.5% fetal bovine serum (Invitrogen Life Tech-
nologies, Carlsbad, CA). Cells were plated at a density of 1
 105 cells per well, in 12-well plates on the day prior to
transfection. Transfections were performed, using FUGENE
6 reagent (Roche Diagnostics Corp., Indianapolis, IN), ac-
cording to manufacturer’s directions. In each well, 0.5 mg
DNA was used for transfection. The ratio of DBH reporter
construct (DBH-luc) to pRL-null (Promega Corp., Madison,
WI) was maintained constant at 24:1. HAND2 or Phox2a
expression plasmids were added at 150 ng/well. For studies
in which the effects of cAMP were assessed, 8-Br-cAMP
was added to a final concentration of 1 mM at 8 h following
transfection. NT-2 cells were maintained in Opti-MEM sup-
plemented with 10% fetal bovine serum (Invitrogen Life
Technologies, Carlsbad, CA). For transfection, 0.3 g DNA
was used per well. NT-2 cells were plated at a density of 1
 105 cells per well, in 12-well tissue culture plates. The
ratio of DBH reporter construct (DBH-luc) to pRL-null
(Promega Corp., Madison, WI) was maintained constant at
24:1. HAND2 or Phox2a expression plasmids were added at
75 ng/well. For NT-2 cells, transfections were done accord-
ing to manufacturer’s directions using Effectene transfec-
tion reagent (Qiagen Inc., Valencia, CA). All cells were
maintained in 5% CO2, 95% air at 37°C. Cells were har-
vested and luciferase reporter activity was measured accord-
ing to manufacturer’s instructions by using a Dual-Lucif-
erase Reporter Assay System (Promega Corp., Madison,
WI) at 48 h following transfection. As an internal control for
transfection efficiency, all transfections contained pRL-null
encoding Renilla luciferase. All luciferase assays are re-
ported as values normalized to 1 based on the ratio of Firefly
to Renilla reporter activity in control transfections. Data are
presented as the mean  S.E.M. of normalized values.
Statistical significance is based on ANOVA and Bonferroni
post hoc test.
Mutagenesis
Potential E-box sites in the DBH promoter were mutated
by using the QuickChange Multi Site-Directed Mutagenesis
Kit (Stratagene, La Jolla, CA), according to manufacturer’s
directions.
Biochemical pull-down assay
Biochemical pull-down assays were performed as previ-
ously described (Firulli et al., 2000). Briefly, bacterial GST-
fusion proteins were induced in BL21 (Novagen) and puri-
fied as described (Smith and Johnson 1988). Purified
bactrial GST-fusion proteins were bound to glutathione-
linked agarose beads and were incubated with 35S-methio-
noine labeled in vitro transcribed and translated HAND1,
HAND2, and Phox2a proteins. Incubations were carried out
for 18 h at 4°C in binding buffer containing 0.3 M sucrose,
1 mM EDTA, 10 mM Tris, pH 8.0, 0.15 M NaCl, 1% Triton
X-100, 1 g/ml leupeptin, 2 g/ml aprotonin, and 1 mM
phenylmethylsulfonyl fluoride (Firulli et al., 2000). Samples
were washed four times in binding buffer containing 0.6 M
NaCl and fractionated in a 10% SDS-PAGE gel. Recovered
proteins were visualized following exposure to Phospho-
rImager screens.
Reporter and plasmid constructs
The DBH-luc construct and mutants were kindly pro-
vided by Elaine Lewis. The DBH-luc reporter construct
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(Swanson et al., 2000) contains the DB1 enhancer and the
proximal DBH promoter (232/12) inserted into pGL3-
Basic (Promega Corp., Madison, WI). The homeodomain
binding mutants (Swanson et al., 2000) were made by site-
directed mutagenesis (QuickChange mutagenesis kit; Pro-
mega, Corp., Madison, WI) of the DBH-luc reporter con-
struct. To construct the HAND2 expression plasmid, the
1100-bp BssHII–DraIII fragment of mouse HAND2 was
cloned into the RsaI site in pcDNA1 (Invitrogen Life Tech-
nologies, Carlsbad, CA). The construction of Arix-pcDNA3
was previously described (Swanson et al., 2000).
dHANDbasic was generously provided by D. McFadden
and E. Olson and has been described (McFadden et al.,
2002). Potential E-box sites in the DBH promoter were
mutated at 68 to 73bp (CAAATG mutated to AG-
GCCT), 88 to 93bp (CAATTG mutated to AAATTT),
and 336 to 341bp (CAGTTG mutated to AAGCTT). A
new restriction site was created in each mutated sequence to
allow for confirmation of the mutation.
Statistical analysis
The data are presented as the mean  S.E.M. Treatment
groups were compared by ANOVA and Bonferroni’s mul-
tiple comparison posthoc test used to determine statistical
significance.
Results
HAND2 synergistically enhances Phox2a activity at the
DBH promoter
The differential requirement for cAMP in the cell type-
specific expression of DBH in noradrenergic precursor cells
in rodent and avian suggested the presence of cell type-
specific coactivators of DBH in addition to Phox2a.
HAND2 was a likely candidate because ectopic expression
of HAND2 is sufficient for the expression of both pan-
neuronal and cell type-specific noradrenergic marker genes
(Howard et al., 2000). As an initial step in elucidating the
function of HAND2 as a coactivator in cell type-specific
transcription of DBH, we employed transient transfection
assays to assess DBH activity. To determine whether
HAND2 functions with Phox2a in regulating transcriptional
activity at the DBH promoter, P19 cells and NT2 cells were
transiently transfected with a DBH-luciferase (DBH-luc)
reporter construct (Swanson et al., 2000) and basal promoterFig. 1. HAND2 synergistically augments Phox2a transcriptional activity at
the DBH promoter. P19 cells (A) and NT-2 cells (B) were transiently
transfected with HAND2, Phox2a, or both expression constructs and wild
type DBH promoter using FuGENE6 (Roche Diagnostics Corp., Indianap-
olis, IN) or Effectene transfection reagent (Qiagen, GMBH, Germany),
respectively. For each transfection, pRL-null was included as an internal
control for transfection efficiency. A total of 0.5 or 0.3 g/well DNA was
used for P19 cells and NT2 cells, respectively. Then 75 ng/well of each
expression plasmid was included for P19 cells or NT2 cells, respectively,
as indicated. Cells were harvested after 48 and luciferase assays performed
on cell lysates. In control studies (C), basal reporter activity of pGL3-basic
and pGL3-promoter (192 ng/well) and reporter activity in the presence of
HAND2 was tested in transient transnfections of P19 cells. Each well
included pRL-null (8 ng/well) as an internal control for transfection effi-
ciency. The data are presented as the mean  S.E.M. (three transfections)
of normalized Firefly/Renilla luciferase units.
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activity was determined (Fig. 1). DBH promoter activity
was then assessed following cotransfection in P19 (Fig. 1A)
and NT-2 (Fig. 1B) cells of the DBH-luc construct and
pcDNA1-HAND2, pcDNA-3-Phox2a, or both expression
constructs. HAND2 stimulates DBH promoter activity only
minimally when expressed alone; on average, DBH reporter
activity is increased 0.3  0.11-fold over control values.
When transfected alone, Phox2a activates the DBH en-
hancer driving transcription of the reporter in P19 and NT2
cells. In response to Phox2a, DBH reporter activity was
significantly increased 8.9  0.7-fold (P  0.001) in P19
cells and 6.4  0.7-fold (P  0.001) in NT2 cells. In the
presence of HAND2, activation of the DBH promoter by
Phox2a is significantly increased (P  0.001) compared
with the stimulated activity of Phox2a alone. In P19 cells
and NT-2 cells, coexpression of HAND2 and Phox2a sig-
nificantly increased reporter activity by 6.5-fold (57.4 
3.7-fold over control) and 3-fold (19.8  2.5-fold over
control) compared with Phox2a, respectively. To confirm
that HAND2 does not interact with pGL3-basic or pGL3-
promoter in our system (Hong et al., 2002), P19 cells were
transiently transfected with pGL3-basic, pGL3-promoter,
and pCDNA1 (Fig. 1C) and Luciferase activity was mea-
sured in response to HAND2. HAND2 failed to increase
Luciferase reporter activity, suggesting that activation of
DBH with HAND2 and Phox2a is specific to DBH. The
increased activity of Phox2a in the presence of HAND2 is
more than an additive effect and thus shows synergistic
activation of DBH. This transcriptional synergy between
HAND2 and Phox2a suggests that these transcription fac-
tors do not function independently of each other at the DBH
promoter, implying a physical interaction between Phox2a
and HAND2 or association through an intermediate pro-
tein(s).
cAMP augments HAND2 and Phox2a transcriptional
activity
Previous promoter analysis of DBH has identified a func-
tional cAMP-response element/activator protein 1 (CRE/
AP1) domain (Swanson et al., 1998). This CRE/AP1 site in
the DBH enhancer mediates responsiveness to cAMP and
the synergistic activation of DBH by Phox2a and PKA
(Swanson et al., 1998). As HAND2 can synergistically
augment activity of Phox2a on DBH transcription, we next
examined effects of cAMP on HAND2/Phox2a modulation
of DBH expression in P19 cells. Results show basal DBH
promoter activity in the presence of HAND2, Phox2a or
HAND2 plus Phox2a is significantly (P  0.001) enhanced
(2.0 to 2.4-fold) by the addition of 1 mM 8-Br-cAMP (Fig.
2). That cAMP could enhance the synergistic activation of
DBH reporter activity by HAND2 and Phox2a suggests that
HAND2 is a cell type-specific coactivator involved in the
stimulated transcription of the DBH promoter. Since the
DBH promoter contains both Phox2a homeodomain core
recognition (HD) sites as well as three putative E-box sites
that could bind HAND2, we sought to define the critical
cis-elements, which mediate the effects of HAND2/Phox2a
and cAMP within the DBH promoter.
To determine whether HAND2 influences transcriptional
activity of Phox2a by affecting some change in Phox2a
binding, we tested the ability of HAND2 to synergistically
augment DBH promoter activity in response to Phox2a
binding in Phox2a homeodomain core recognition site mu-
tants. There are three homeodomain binding sites in the
DBH proximal promoter (Swanson et al., 2000) which act in
a coordinated manner in the cell type-specific regulation of
DBH expression. Homeodomain core recognition sites 1
and 2 (HD1/2) impart cAMP responsiveness (Swanson et
al., 2000). In both P19 and NT-2 cells, stimulated transcrip-
tion is reduced in the HD1/2 mutant (Fig. 3). Neither
HAND2 (Fig. 3) nor Phox2a in the presence or absence of
cAMP (Fig. 4) stimulated transcription of the HD1/2 mutant
reporter, suggesting that the homeodomain sites in the DB1
enhancer region of the DBH promoter are necessary for
transcriptional activation and HAND2-Phox2a synergy.
This conclusion was further tested by repeating this assay
using a reporter construct lacking the more proximal home-
odomain core recognition site 3 (HD3) (Swanson et al,
2000). Wild-type promoter reporter activity was increased
8-fold by Phox2a and 35-fold in the presence of HAND2
plus Phox2a (Fig. 3). Wild-type activity was stimulated an
additional 2.5-fold by treatment with 1 mM 8-Br-cAMP
enhancing basal promoter activity to 87-fold (Fig. 4). In the
HD3 mutant, HAND2 and Phox2a show no significant
change in luciferase activity, while HAND2 in the presence
of 1 mM 8-Br-cAMP increased reporter activity 2.8-fold.
HAND2 and Phox2a, in the presence of 1mM 8-Br-cAMP,
significantly (P  0.01) increased basal reporter activity
9-fold (Fig. 4), suggesting that HD1/2 mediates a portion of
HAND2-Phox2a DBH activation. Taken together, the data
suggest that, in P19 cells, HD1/2 and HD3 are required for
Fig. 2. cAMP augments HAND2 activation with Phox2a of the DBH
promoter. P19 cells were transiently transfected with pCDNA1-HAND2
(75 ng/well), and/or pCDNA3-Phox2a (75 ng/well) expression constructs
and wild type DBH promoter reporter construct using FuGENE6 transfec-
tion reagent (Roache Diagnostics Corp., Indianapolis, IN). Cells were
grown in the presence or absence of 1 mM 8-Br-cAMP for 48 h and
luciferase assays performed on cell lysates. Data are presented as mean 
S.E.M. normalized luciferase activity from three independent transfections.
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Phox2a activity but that HD1/2 maintains significant
Phox2a activity in the absence of HD3. In addition, HD1/2
is required for the cAMP effect in the presence of HAND2.
HAND2 function at the DBH promoter does not require
direct DNA binding
In initial studies to investigate the mechanism of
HAND2 activity at the DBH promoter, we took two ap-
proaches. In the first, we used site-directed mutagenesis to
abolish each of three potential E-box binding domains in the
DBH promoter and assessed the effect on DBH-luc reporter
activity (Fig. 5A). For each assay, P19 cells were transiently
transfected with HAND2, Phox2a, or HAND2 plus Phox2a
and DBH-reporter activity was measured after 48 h. Basal
reporter activity was increased 10-fold by Phox2a at the
native DBH promoter or in the E-box mutants. In the pres-
ence of HAND2, Phox2a increased DBH reporter activity
38- to 48-fold (Fig. 5A). There was no significant difference
between transactivation of the native versus any of the three
E-box mutants. This suggested that direct DNA binding was
not required for HAND2 to function as a coactivator with
Phox2a at the DBH promoter.
We further tested the conclusion that HAND2 does not
bind DNA directly (Fig. 5B) by determining the activity of
a basic domain deletion mutant (dHANDbasic, kindly
provided by E. Olson) on Phox2a stimulation of DBH
reporter activity. Basal DBH promoter activity was in-
creased 13-fold in the presence of Phox2a and either native
HAND2 or HAND2basic. Deletion of the HAND2 DNA
binding domain had no effect on reporter activity in re-
sponse to Phox2a, suggesting that HAND2 functions by
protein–protein interaction and not by binding to the DBH
promoter.
HAND2 does not physically interact with Phox2a
HAND2 can function as a coactivator of DBH transcrip-
tion independent of DNA binding. This result raises the
possibility that HAND2 physically interacts with Phox2a.
To test the possibility that HAND2 physically interacts with
Phox2a, we used a biochemical pull-down assay. A bacte-
rial HAND2-GST fusion protein was immobilized onto glu-
tathione-linked agarose beads and incubated with 35S-me-
thionine-labeled in vitro transcribed and translated protein
(Firulli et al., 2000). Protein retained on glutathione-linked
beads was fractionated in a SDS-PAGE gel and detected
Fig. 4. cAMP augmentation of DBH transcriptional activity requires
Phox2a HD binding domains. P19 cells were transiently transfected with
either the wild type DBH-luc or HD mutant reporter constructs, pCDNA1-
HAND2 and pCDNA3-Phox2a, in the presence or absence of 1 mM
8-Br-cAMP. Following 48 h of cell growth, luciferase assays were per-
formed on cell lysates. pRL-null was included in each transfection as an
internal control for transfection efficiency. Data are presented as the nor-
malized luciferase activity based on the ratio of Firefly/Renilla luciferase
activity. Each point represents the mean  S.E.M. of three independent
transfections.
Fig. 3. HAND2 transcriptional activity requires Phox2a binding at HD
sites. P19 cells (A) and NT-2 cells (B) were transiently transfected, as
described above in Fig. 1, with HAND2, Phox2a, or both expression
constructs with either the wild type DBH-luc or HD mutant reporter
constructs (described under Materials and methods). For each transfection,
pRL-null was included as an internal control for transfection efficiency.
Luciferase assays were performed on cell lysates following 48 h of cell
growth. Data are presented as the normalized luciferase activity based on
the ratio of Firefly/Renilla luciferase activity. Each point represents the
mean  S.E.M. of three independent transfections.
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following exposure on a PhosphorImager (Fig. 6). GST-
HAND2 failed to pull-down Phox2a, suggesting that
HAND2 and Phox2a do not physically interact in the tran-
scription complex formed at the DBH promoter. As a con-
trol, GSTHAND2 beads were incubated with HAND2 and
HAND1. The formation of HAND2 homodimers and
HAND1–HAND2 heterodimers has been previously re-
ported (Firulli et al., 2000) and suggested the possibility that
HAND2 homodimers might be functional in the combina-
torial synergy observed at the DBH promoter. This was
tested indirectly by determining whether HAND2 function-
ally dimerizes with E12 to enhance Phox2a transcriptional
activity. Cotransfection of pCS2E12, pcDNA1-HAND2,
and pcDNA3-Phox2a in P19 cells demonstrates that E12
has no effect on either basal DBH promoter activity or
Phox2a stimulated transcription (Fig. 7). In agreement with
Dai et al. (2002b). E12 significantly reduced (P  0.001)
synergistic activation of DBH by HAND2 without affecting
a change in the activity of Phox2a. This result suggests that
Fig. 5. HAND2 synergistically augments Phox2a stimulated DBH pro-
moter activity in the absence of DNA binding. (A) P19 cells were tran-
siently transfected with wild type DBH-luc (192 ng/well) or E-box mutant
DBH-luc (192 ng/well) in the presence of pCDNA1-HAND2, pCDNA3-
Phox2a, or pCDNA1-HAND2 plus pCDNA3-Phox2a (75 ng/well). Cell
lysates were made after 48 h growth and luciferase reporter activity was
measured. (B) P19 cells were transiently transfected with wild type
pCDNA1-HAND2 or pCDNA1-HAND2basic (75 ng/well), lacking the
DNA binding domain, and the wild type DBH-luc reporter construct (192
ng/well). pRL-null was included in each transfection as an internal control
for transfection efficiency. After 48, cells were harvested and luciferase
assays on cell lysates were performed. The data are presented as the mean
 S.E.M. of normalized luciferase activity from three independent trans-
fections.
Fig. 6. HAND2 and Phox2a do not physically interact. Either GST or a
GST fusion for HAND2 or HAND1, were bound to Glutathione beads and
incubated with 35S-labeled, in vitro transcribed, and translated HAND2 or
Phox 2a. The bead-bound proteins were fractionated in a 10% SDS-PAGE
gel and then visualized via phosphorimager.
Fig. 7. E12 titrates HAND2 synergy with Phox2a. P19 cells were tran-
siently transfected with a mixture of DNA containing the reporter plasmid
DBH-luc (192 ng/well) and pRL-null (8 ng/well) using FuGENE6 Trans-
fection Reagent (Roche, Indianapolis, IN) according to manufacturer’s
directions. Then 75 ng/well of pCDA1-HAND2, pCDNA3-Phox2a, or
CS-MT2E12 were included as indicated. The total amount of DNA was
adjusted to 0.5 g/well using pCDNA1. Cells were harvested at 48 h and
luciferase activity was measured in cell lysates. The data are presented as
the mean  S.E.M. of normalized luciferase activity from three indepen-
dent transfections.
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HAND2 dimerizes with another partner, independent of
E-proteins, which may be HAND2 in this context. These
results suggest that synergy between HAND2 and Phox2a is
the result of protein–protein interaction in a transcriptional
complex at the DBH promoter.
Synergistic activation of DBH by HAND2 and Phox2a
requires CBP/P300
The functional synergy between HAND2 and Phox2a
could result from the recruitment of other regulatory mole-
cules. Both HAND2 and Phox2a interact with CBP/P300
(Dai et al., 2002; Swanson et al., 2000), and this interaction
has been shown to increase transcriptional activity. We used
the CBP/P300 inhibitory protein E1A to determine whether
CBP/P300 is a cofactor that might mediate the functional
interaction of HAND2 and Phox2a. Cotransfection of
pBJ9E1A significantly inhibited DBH reporter activity (Fig.
8). In the presence of E1A, promoter activity was potently
inhibited (100%) in response to HAND2, Phox2a, or
HAND2 plus Phox2a. This result suggests that the syner-
gistic activation of DBH reporter activity by HAND2-
Phox2a requires CBP/P300. This conclusion was further
tested by deleting the majority of the DBH enhancer, con-
taining the CRE/AP1, HD1, and HD2 domains, from 232
to 125 of the DBH promoter (DBH-125-luc) leaving only
the HD3 domain and the TATA box (Fig. 9A) or by mu-
tating the CRE to render it inactive (Fig. 9B). In P19 cells
cotransfected with HAND2, Phox2a, and DBH-125-luc,
synergistic activation of DBH by HAND2 is reduced 100%.
This result suggests that synergy requires sites within the
DB1 enhancer and that Phox2a alone is inadequate for
HAND2 function. The site within the DB1 enhancer re-
quired for HAND2 synergy is the CRE domain. Transient
transfection of P19 cells with wild-type DBH-luc or with a
CRE mutant (CREDBH) resulted in a complete loss of
HAND2 synergy with Phox2a (Fig. 9B). Mutation of the
CRE domain also resulted in a significant reduction in
HAND2 basal activity, suggesting that, in the basal state,
CBP/P300 may constitutively reside at this site as is sug-
gested by the loss of basal promoter activity in the presence
of EIA (Fig. 8). Within HAND2, the CBP/P300 binding
domain lies within the bHLH domain (Dai et al., 2002). We
deleted the bHLH (HAND2bHLH) domain from HAND2
(Fig. 9C) and tested synergistic activation of DHB with
Phox2a. All synergistic activity of HAND2 is lost if the
bHLH domain is deleted. Together, the data suggest that
synergistic activation of DBH occurs with Phox2a binding
at HD binding sites and HAND2 interacting in a higher
order complex with CBP/P300 which occurs independent of
DNA binding but requiring the bHLH domain of HAND2.
Discussion
One hallmark of the differentiation of neurons is the
coordinated expression of pan-neuronal and cell type-spe-
cific phenotypic characteristics. For neural crest-derived
noradrenergic neurons, many of the critical regulatory genes
have been identified (for review, see Goridis and Rohrer,
2002), but the mechanisms governing their interactions
have not been well established. HAND2 has been impli-
cated as a pivotal player in the differentiation of neural
crest-derived noradrenergic sympathetic ganglion neurons.
Unlike other transcription factors required for the differen-
tiation of noradrenergic neurons, such as Phox2a, Phox2b,
and MASH-1, which are also expressed in a diverse array of
nonnoradrenergic neurons, the neural expression of
HAND2 is confined to sympathetic and enteric neurons
(Howard et al., 1999; Wu and Howard, 2002). In the present
studies, we undertook to examine the function of HAND2 in
regulating the cell type-specific gene, dopamine--hydrox-
ylase (DBH). Our data suggest that HAND2 is a cotrans-
criptional regulator of DBH. HAND2 transcriptional regu-
lation of DBH is independent of direct DNA binding and
dependent on the HLH domain. The HAND2 synergy with
Phox2a is mediated not by direct protein–protein interaction
but through an intermediate factor that is likely CBP/P300.
Collectively, our data suggest HAND2 is a cell type-specific
regulatory molecule contributing to the expression of nor-
epinephrine.
Previous results suggested the possibility that HAND2
and Phox2a act together in the cell type-specific expression
of the noradrenergic marker gene DBH. The ectopic expres-
sion of HAND2, both in vitro (Howard et al., 1999) and in
vivo (Howard et al., 2000), is sufficient for development of
cells expressing both pan-neuronal and noradrenergic cell
type-specific markers. The induction of Phox2a by HAND2
most likely accounts, in part, for the subsequent expression
of TH, DBH, and NE (Howard et al., 2000). Thus, HAND2
Fig. 8. HAND2 synergy with Phox2a is dependent on transcriptional
coactivators. P19 cells were transiently transfected (FuGENE 6 Transfec-
tion Reagent) with DBH-luc (192 ng/well) and pCDNA1-HAND2 (75
ng/well), pCDNA3-Phox2a (75 ng/well), or E1A 12S (75 ng/well), as
indicated. pCDNA1 vector DNA was added to adjust the final DNA to 0.5
g/well. Cells were harvested at 48 h and Luciferase activity was measured
in cell lystes. The data are presented as the mean  S.E.M. of normalized
luciferase activity from three independent transfections.
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Fig. 9. The cis-acting domain for HAND2 synergistic activation of Phox2a resides in the DB1 enhancer. (A) The DB1 enhancer was deleted from DBH-luc
by removing bases from 225 to 126 with EcoRI and HindII. The resulting mutant (DBH-125-luc) was used (192 ng/well) in transient transfection assays
in P19 cells. Cells were transfected with 75 ng/well of pCDNA1-HAND2, and pCDNA3-Phox2a as indicated. The total DNA was adjusted with pCDNA1
to 0.5 g/well. At 48 h, cells were harvested, and lysates were made by using the Dual-luciferase Reporter Assay System from Promega (Promega Corp.,
Madison, WI). The data are presented as the mean  S.E.M. of normalized luciferase activity from three independent transfectons. (B) The CRE motif of
the DBH promoter was mutated by using the primer DBH-CREM (CTTGAATGATGTCCATGaatATTAGTGTCAATTAGGG), from 188 to 150 bp by
site-directed mutagenesis (DBHCRE). Wild-type and DBHCRE were used in transient transfection assays, as in (A), to assess the effect of the CRE on
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can be added to the growing list of bHLH DNA binding
proteins that link expression of pan-neuronal and cell type-
specific genes. Evidence is mounting implicating bHLH
factors as transcriptional coactivators, regulating function of
phenotype-specific marker genes, in a variety of cell types.
In addition to the interaction we demonstrate for HAND2,
Phox2a, and DBH, synergistic interactions have been dem-
onstrated for HAND2, GATA4, and Nkx2.5 in the regula-
tion of the cardiac-specific gene, atrial naturetic peptide
(Thattallyath et al., 2002; Dai et al., 2002). Both GATA4
and Phox2a bind the transcriptional coactivator CBP/P300
(Dai et al., 2002; Dai and Markham, 2001; Swanson et al.,
2000), suggesting a model by which cAMP stimulated
downstream effector molecules might interact in a higher
order transcriptional complex to regulate DBH.
Cyclic-AMP regulates transcription of the DBH gene
(Shaskus et al., 1992; Ishiguro et al., 1993 Kim et al., 1994;
Swanson et al., 1997). Although cAMP/PKA had a modest
effect on HAND2 transactivation of DBH in the absence of
Phox2a, the interaction of HAND2 with Phox2a is enhanced
greater than two-fold in the presence of cAMP/PKA. The
function of cAMP/PKA in norepinephrine synthesis most
likely occurs by regulating Phox2a activity and by recruit-
ment of an AP1 complex to the CRE site adjacent to the
Phox2a binding site HD1 (Swanson et al., 2000; Adachi and
Lewis, 2002; Kim et al., 1998). Regions within the DBH
enhancer which regulate basal activity, cell type-specific
expression, and cAMP responsiveness are located between
180 and 150 in the rat gene (Shaskus et al., 1992;
Ishiguro et al., 1993; Afar et al., 1996). The close proximity
of these regulatory domains suggested interactions between
HAND2, Phox2a, and transcriptional coactivators to regu-
late tissue specific DBH expression. Synergistic activation
of DBH by HAND2 is mediated by interaction with se-
quences included within the DB1 enhancer and independent
of HD3. In our domain mapping studies, we have shown
that deletion of CRE/AP1, HD1, and HD2 sites from the
DBH promoter results in a complete loss of HAND2-me-
diated synergistic activation of Phox2a supported transcrip-
tion at HD3. This result suggests that Phox2a binding at
HD3 is inadequate for transactivation of DBH (Swanson et
al., 2000) and that Phox2a alone is insufficient for syner-
gistic activation by HAND2. Synergistic activation of
Phox2a by both cAMP and HAND2 raised the possibility
that HAND2 interacts in a combinatorial fashion in a tran-
scription factor scaffold at the DBH promoter.
In the heart, HAND2 participates in transcriptional com-
plexes comprised of CBP/P300, GATA4, and Nkx2.5, that
regulate tissue-specific gene expression (Thattallyath et al.,
2002; Dai et al., 2002). It is possible that HAND2 functions
to mediate the response to cAMP, at the DBH promoter, via
a higher order complex containing HAND2, CBP/P300, and
Phox2a. In the presence of EIA, which blocks a broad array
of transcriptional coactivators, including CBP/P300 (Moran
1993; Arany et al., 1995; Lundblad et al., 1995), transcrip-
tion of DBH is refractory to Phox2a, HAND2, and cAMP.
Basal DBH reporter activity is also reduced, suggesting that
CBP/P300, or a similar molecule, is constitutively present
regulating basal promoter activity. This idea is supported by
the finding that DBH basal promoter activity can be in-
creased up to three times by incubating cells with 8-bromo-
cAMP (M.J.H., unpublished data; Swanson et al., 1997) and
that mutation of the CRE domain within the DB1 enhancer
results in a loss of HAND2 synergistic activation of DBH
with Phox2a. HAND2 physically interacts with the CH3
domain of P300 via its bHLH domain (Dai et al., 2002) and
Phox2a interacts with the CH3 domain of CBP (Swanson et
al., 2000), suggesting that transcription of DBH is regulated
by a scaffold of transcription factors and coactivators. In the
context of the DBH promoter, the bHLH domain of HAND2
is required for synergistic activation of DBH transcription.
All synergistic activity is lost if the bHLH domain is re-
moved from HAND2. Similar results have been reported in
tissue-specific regulation of ANP (Dai et al., 2002) as well
as proper patterning of the limb by HAND2 (McFadden et
al., 2002). Taken together, similar results in three different
systems suggest that, for some aspects of tissue-specific
gene regulation, the functional activity of HAND2 resides
within the bHLH domain, although interactions with addi-
tional coactivators cannot be ruled out.
Classically, tissue-specific bHLH DNA binding proteins,
such as HAND2, are thought to form heterodimers with
ubiquitous bHLH DNA binding proteins, and this complex
then binds to E-box consensus (CANNTG) motifs to regu-
late transcription of target genes (Massari and Murre, 2000).
Our results could be explained by HAND2 heterodimers
binding to putative E-box sites within the DBH promoter or
by HAND2 interacting with Phox2a in the transcriptional
complex. If the molecular mechanism underlying HAND2
synergistic activation of DBH were mediated through bind-
ing to E-box sequences, we would have expected to dimin-
ish synergistic activation by mutation of potential E-box
sites within the DBH promoter. Our finding that mutation of
each of three potential E-box sites within the DBH promoter
did not abrogate the synergistic enhancement of transcrip-
tion suggests that HAND2 can regulate the activity of target
genes in a DNA-independent manner. As we were unable to
construct the triple E-box mutant, we used a basic domain
mutant lacking the DNA binding motif (McFadden et al.,
2002) to confirm that HAND2 function is independent of
HAND2 synergy. (C) To determine whether HAND2 functional activity resides within the bHLH domain, this region was deleted by digesting the
dHANDbasic construct with HindIII and BamHI and the resulting fragment blunt ended and religated to remove a KpnI site within the vector backbone.
This plasmid was digested with AvrII and KpnI to yield a 4.4-kb fragment. The KpnI terminus was blunt ended and religated with a 1.5 kb StuI/AvrII fragment
to obtain HAND2bHLH. These constructs were identified by restriction digestion, PCR, and functional assay. Transient transfections were performed as
described in Materials and methods.
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direct DNA binding. Removal of the basic DNA binding
domain from HAND2 did not negatively influence HAND2
synergistic enhancement of Phox2a transcriptional activity,
indicating that HAND2 regulates Phox2a directed DBH
transcription independent of DNA binding. A similar mech-
anism has been reported for HAND2 in limb bud and heart.
In the heart, HAND2 regulates transcription of the cardiac-
specific gene, ANP, independent of DNA binding (Thattal-
iyath et al., 2002; Dai et al., 2002). HAND2 is required for
proper limb morphogenesis (Charite et al., 2000; Fernan-
dez-Teran et al., 2000; te Welscher et al., 2002) but func-
tions in limb patterning independent of direct DNA binding
(McFadden et al., 2002). In transgenic mice, wild-type
HAND2 and dHANDbaic have equivalent activity in gen-
eration of preaxial polydactly, similar to the equivalence we
report for synergistic activation of DBH. This provides
support for the notion that the basic region of HAND2 is not
necessary for mediating all of the biological functions as-
cribed to HAND2. This would suggest that the ability of
HAND2 to interact with other proteins within a transcrip-
tional complex is mediated by targeting independent of
DNA binding.
It remained possible that we had not identified all poten-
tial E-box sites within the DBH promoter. A recent report
by Hong et al. (2002) suggested that HAND proteins may
directly activate Luciferase reporter activity independent of
promoter activity. However, in our system, interaction of
HAND2 with sequence motifs in pGL3 does not occur.
Deletion of the DBI enhancer abrogated HAND2 synergis-
tic activation of Phox2a-mediated DBH transcription, sug-
gesting specificity of HAND2-Phox2a transcriptional con-
trol. Our studies further suggest that HAND2 does not
function as a heterodimer with the E-protein E12, in the
context of the DBH promoter. Since E12 can titrate HAND2
transcriptional activity of DBH, HAND2-E12 dimers must
not be active at this complex, although HAND2 has been
shown in a mammalian two-hybrid assay to dimerize with
E12 (Dai and Cserjesi, 2002). The formation of HAND2
homodimers has been demonstrated in vitro and in vivo
(Dai and Cserjesi, 2002; Firulli et al., 2000), although there
is not general agreement as to the transcriptional activity of
HAND2 homodimers. In the developing limb, HAND2 does
not appear to dimerize with E-proteins in the DNA binding-
independent regulation of limb patterning (McFadden et al.,
2002). We suggest that HAND2 functions in tissue-specific
gene regulation in a novel manner encompassing both the
choice of dimerization partner as well as DNA binding
activity. HAND2 is expressed and has been shown to have
a role in a variety of tissues with very different develop-
mental history and function. The diverse array of HAND2
mediated responses may be due in part to the novel ability
of HAND2 to function independent of DNA binding, to
bind to a large array of dimerization partners, and partici-
pate in scaffolds of transcription factors and coactivators.
We tested the possibility that the proteins encoded by
HAND2 and Phox2a bind each other directly but could not
demonstrate such interactions using both IP/Westerns
(A.B.F., unpublished observation) and GST-fusion protein
pull down assays. Based on our results and those of Dai et
al. (2002) and McFadden et al. (2002), HAND2 can func-
tion in tissue-specific gene expression by recruiting proteins
to a transcriptional complex and synergistically altering
transcription in the absence of direct DNA binding. We
propose that HAND2 acts as a bridge between Phox2a and
CBP/P300 and modulates transcription of DBH, thus influ-
encing tissue-specific gene expression in noradrenergic neu-
rons. At the present time, we are unable to rule out the
possibility that HAND2 recruits additional coactivators to
the DBH promoter, carrying out its function at a site discrete
from those we have identified in the DB1 enhancer.
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